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Fc receptors occur on  several hematopoietic cell lineages, and can mediate 
crucial effector functions in  each of the cell types. The  Fc receptors on mast 
cells,  macropbages  (1-5),  granulocytes (6-9),  and  lymphocytes (10-21)  have 
been shown to exhibit different binding specificities. Moreover, in some cases 
distinct Fc receptor-binding specificities are found on a single cell (8, 9,  13, 21- 
29). Murine macrophages, which have been studied extensively, appear to possess 
three distinct  Fc  receptors for  IgG,  one binding  IgG1  and  IgG2b,  a  second 
binding IgG2a, and a third binding IgG3 (22-29). The IgG2a receptor is sensitive 
to  trypsin  proteolysis and  fails  to  bind  IgG2a  at  4°C  or  in  the  presence  of 
cytochalasin. In contrast, the IgG1/IgG2b and IgG3 receptors are unaffected by 
these treatments (22-24,  27,  28).  In addition, mutant cell lines lacking certain 
receptor activities have been  isolated and the receptors can be independently 
modulated (22-24, 29). In contrast, Fc receptors isolated by affinity chromatog- 
raphy on IgG2a- or IgG2b-Sepharose or by immunoprecipitation bind equally 
well to IgG1, IgG2a, and IgG2b (26, 30). However, affinity-isolated Fc receptors 
can, under certain circumstances, distinguish between IgGl/IgG2b and IgG2a 
(31). In contrast to our understanding of macrophage and mast cell Fc receptors, 
little is known about Fc receptors on lymphocytes (20). 
Immunoglobulin binding to cell surfaces via Fc receptors mediates immuno- 
logical effector fimctions. The opsonization of immune complexes and particulate 
antigens  (32-34),  as  well  as  the  release  of molecules that  regulate  immune 
responsiveness  (35,  36),  are  facilitated  by  IgG  binding  to  Fc  receptors  on 
macrophages.  Mast  cell release of histamine is  mediated by antigen-IgE com- 
plexes  bound  to  the  IgE  Fc  receptor  (37-39).  Further,  T  cell  binding  of 
immunoglobulin via  Fc receptors appears  to  result in  modulation of immune 
responses (40-43).  For example, Fc binding of IgE by T  cells elicits release of 
IgE-binding factors which act  to  regulate  the  IgE  response  (40,  41).  Similar 
results have been found with T  cells that bind IgG and IgA by means of their Fc 
receptors (42, 43). Indeed, in the majority of systems where the cellular basis of 
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Fc-mediated immune  modulation  has  been examined,  T  cells or  macrophages 
appear to be involved (40-46). There is one system however, where the B cell is 
apparently directly affected by Fc binding of IgG (47). B cells treated with whole 
rabbit  anti-mouse  IgM  do  not  induce  B  cells to proliferate, although  F(ab')2 
fragments do. Recent results (48) indicate that whole anti-Ig does lead to B cell 
depolarization,  enlargement,  and  enhanced  Ia  antigen  expression.  Thus,  al- 
though  B  cells become activated by whole anti-Ig,  Fc-mediated binding of the 
anti-Ig seems to inhibit  DNA synthesis.  The crosslinking of surface Ig (sIg) ~ to 
Fc receptors appears to act as a  regulatory signal acting directly on the B cell. 
To  better  understand  this  potentially important  B  cell receptor(s),  we  have 
begun to characterize those capable of binding IgG. Our results indicate that a 
single Fc receptor binds both rat and mouse IgGs of the IgG1, IgG2a, and IgG2b 
subclasses.  Furthermore,  we  find  that  B  cells of A/J,  AL/N,  and  NZB/J  mice 
bind 3.5-7-fold less rat IgG than B cells of other strains, reflecting a  difference 
in the specificity of the IgG Fc receptor rather than a difference in the number 
of Fc receptors expressed by A/J  B  lymphocytes. An examination of backcross 
mice and Igh recombinant mouse strains indicates that Fc receptor polymorphism 
is loosely linked to the Igh  locus of chromosome  12 and maps telomeric to the 
prealbumin locus. 
Materials and Methods 
Mouse Strains.  Adult  BALB/cJ,  C57BL/6J,  C57BL/10J,  SjL/j,  DBA/2J,  AKR/J, 
A/J, a/HeJ, NZB/BLJ, CE/J, P/J, CBA/J, C3H/FeJ, and PL/J mice were obtained from 
The Jackson Laboratory (Bar Harbor, ME) and breeding facilities at Washington Univer- 
sity.  AL/N,  C.AL9, and C.AL20  mice were obtained from Dr.  Michael  Potter (NIH, 
Betbesda, MD). 
Igh recombinant mouse strains, AXC and CXAXCB were constructed by crossing mice 
with different allotypes and selecting for recombination between the Igh-V marker locus 
(IgH-Dex) and the Igh-C marker allotype, or for recombinations between Igh-C and Pre-l, 
the serum prealbumin locus (49-51). 
Cells and Culture Conditions.  Normal lymphoid cell populations were separated into 
T  and B cells by panning. Polystyrene dishes (16 x  100 mm, No. 1001; Falcon Labware, 
Oxnard, CA) were coated with affinity-purified goat anti-mouse IgM or mouse anti-rat 
Ig  according to  the  method  of Wysocki and  Sato  (52).  Briefly, 5-10  ml  of purified 
antibody (10 #g/ml) in 0.05 M Tris, 0.15 M NaCI, pH 9.5 was added to polystyrene dishes 
for  1 h  at  room  temperature.  Dishes  were  then  washed  in  phosphate-buffered saline 
(PBS)/1% fetal calf serum (FCS) and further incubated in PBS/1% FCS to block remaining 
protein-binding sites.  For indirect panning,  plates coated with  mouse anti-rat  Ig were 
incubated with appropriate amounts of monoclonal antibody 14.8, directed to the B cell 
marker B220 (53) or monoclonal anti-Thy-l.2 (Jlj)  (54) for  1 h at room temperature. 
Plates were thoroughly washed and spleen cells (2  x  107) were gently layered onto the 
plates in Dulbecco's modified Eagle's medium (DME), 5% FCS and incubated at 4°C for 
60 min. Nonadherent cells were removed in eight washes after which adherent cells were 
harvested by vigorous pipeting. 
T and B cell blasts were induced by mitogen stimulation and purified on Percoll density 
gradients in some experiments. Briefly, spleen cells were treated with either concanava[in 
A (Con A) (2 ~g/ml) or lipopolysaccharide (LPS) (50 t~g/ml). Cells were cultured in DME 
supplemented with  glucose,  sodium  bicarbonate,  nonessential amino acids,  glutamine, 
i Abbreviations  used in this paper:  AV, avidin; BSA, bovine serum albumin; Con A, concanavalin 
A; DME, Dulbecco's modified Eagle's medium;  DNP, dinitrophenyl;  FACS, fluorescence-activated 
cell sorter; F1TC, fluorescein isothiocyanate; FCS, fetal calf serum;  LPS,  lipopolysaccharide; PBS, 
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penicillin,  streptomycin,  10%  FCS, and 5  x  10 -5  M  2-mercaptoethanol. Cultures were 
maintained in a humidified incubator at.37°C  with  5% CO2,  7% 02,  88%  N2. Con A- 
treated cells were harvested on day 2 after stimulation and LPS blasts were collected on 
day 3.  The blasts were then isolated and analyzed by fluorescence-activated cell sorter 
(FACS). 
Fluorescent Antibody-bindingAssay.  4 ×  105 cells in DME/0.5% bovine serum albumin 
(BSA)/0.02 M NaN3 were placed in individual wells of V-bottom 96-well microtiter dishes 
(Dynatech Laboratories, Alexandria, VA), and optimal amounts of antibodies in a volume 
of 30 #1 were added to each well.  Cells were incubated on ice for 30 min. Each sample 
was underlaid with 10% BSA in DME containing 0.02 M NaN3 and centrifuged at 250 × 
g for 10 min. This step was repeated after aspiration of the supernatant and resuspension 
of  the  cells.  After  the  second  wash,  cells  were  resuspended  in  25  zl  of  fluorescin 
isothiocyanate (FITC)-mouse anti-rat Ig or FITC-goat anti-mouse IgG (Southern Biolog- 
ical Associates, Birmingham, AL) for 30 rain on ice. FITC-mouse anti-rat Ig and FITC- 
goat anti-mouse IgG were spun at 120,000 g for 30 min to remove aggregated antibody. 
Samples were underlaid with BSA and centrifuged as before. Cells were resuspended in 
50  t~l  DME/0.5%  BSA/0.02  M  NaNz  containing  10  #g/ml  propidium  iodide  (Sigma 
Chemical Co., St.  Louis, MO). Propidium iodide (red fluorescence) was used to exclude 
dead cells from analysis (55).  Biotin-conjugated antibodies were also used in combination 
with FITC-avidin (AV) or phycoerytbrin (PE)-AV to detect cells (56).  PE was obtained 
from Molecular Probes, Junction City, OR.  In dual-fluorescence studies, the procedure 
outlined above was duplicated except that a rat anti-mouse kappa (hybridoma 187. I) (57) 
conjugated to PE was used to identify B cells. 
Monoclonal anti-B220 (14.8) (53), anti-~ (187.1) (57), anti-IgM (331.12) (58), and anti- 
I-A  b (25-9-17) (59) were obtained from the Cell Distribution Center at the Salk Institute, 
La Jolla, CA. Anti-Thy-l.2 (Jlj) (54) and anti-6  "'° (AF4-73.3) (60) were kindly provided by 
Drs. T. McKearn (Cytogen, Inc., Philadelphia, PA) and A. Stall (Becton, Dickinson & Co., 
Mountain View, CA), respectively. Anti-FcR monoclonal (2.4G2) was kindly provided by 
Dr. J. C. Unkeless (25) (The Rockefeller University, New York). 
Cells were analyzed on a FACS IV equipped with an argon ion laser tuned to 488 nm 
and operating at 200 mW of power. Photomultiplier tube voltage and gain setting were 
constant throughout all experiments. Fluorescence histograms were generated with loga- 
rithmic amplification (log base 10) of fluorescence emitted by single viable cells. 
Inhibition Assays.  Titrations of the biotin-conjugated or FITC-labeled IgG were per- 
formed to determine at which point slightly less than maximal staining was observed, so 
that labeled IgG was limiting. The fluorescence assay used to detect optimal Ig binding 
to B lymphocyte Fc receptors requires approximately 10-100 times the concentration of 
purified antibodies that provides optimal staining for immunofluorescence when  using 
antibodies specific for cell surface determinants.  Under conditions where labeled IgG is 
limiting,  inhibition  by  unlabeled  IgGs  can  be  quantitated.  Aggregated  myeloma  or 
hybridoma isotype standards were titrated into a constant number of cells (3 ×  105) and 
allowed to incubate for 5  min. A  constant amount (~50/zg/ml) of labeled IgG is then 
added at 4°C  for 25-30  rain.  The cells are washed and analyzed for fluorescence, as 
described above. Inhibition was measured as the decrease in relative fluorescence intensity 
caused by the competing IgG. 
Myeloma and Hybridoma Antibody Standards.  Murine myeloma proteins were obtained 
by injecting MOPC-21 (IgG1), MPC-11 (IgG2b), LPC-1, UPC-10 (IgG2a), or J606 (IgG3) 
cells into the peritoneal cavity of pristane-primed BALB/c mice (61). The ascites fluid was 
precipitated with 50% saturated ammonium sulfate. The proteins were isolated by DEAE 
chromatography and  preparative isoelectric focusing.  Affinity-purified murine  hybrid- 
omas 32-1A  (IgG2a, anti-dinitrophenyl  [DNP]),  29-13  (IgG2b, anti-DNP),  and  HDP-1 
(IgG1, anti-DNP) (kindly provided by Dr.  M.  Scott,  Mallinckrodt,  Inc., St.  Louis,  MO) 
were also used as isotype standards. 
Rat hybridoma antibodies of IgG1, IgG2a, IgG2b, and IgG2c isotypes were produced 
in our laboratory using standard methods. The affinity-purified antibodies used in these 
studies were:  IgG1 (49C2D3,  anti-DNP),  IgG2a (50C1C1,  anti-DNP),  IgG2b (148d4-1, BAUM, McKEARN, RIBLET, AND DAVIE  285 
anti-N-acetylglucosamine), and IgG2c (120 a3-5, antiphosphorylcholine).  EA4.1 (IgG2b, 
unknown specificity) was also used in these studies as an isotype standard.  Rat myeloma 
proteins IR595 (IgG 1) and IR418 (IgG2a) were kindly provided by Dr. H. Bazin (Univer- 
sity of Louvain,  Belgium)  (62). Aggregated immunoglobulins  were produced using bis- 
diazotized  benzidine (63) or by heat aggregation. 
Results 
IgG Binding to Mouse B Lymphocyte Fc Receptors.  In the studies reported here, 
we  used a  fluorescence assay to quantitate  Fc binding  of immunoglobulins  to 
mouse B lymphocytes. The advantage of a fluorescence assay using flow micro- 
fluorometry  techniques  is  that  individual  cells  are  analyzed  for  Fc  receptor 
expression. Further, the fluorescence assay provides a strong signal that is highly 
reproducible between assays and is stable for several hours at 4°C.  In data not 
shown, we found that isolated B lymphocytes (slgM  +) and LPS blasts bound IgG 
strongly; however, we did not detect significant IgG binding to isolated T  (Thy- 
1  ~2 +) cells or Con A blasts. 
In most of the experiments, we used LPS blasts as our test population because 
they provide a  population of pure B cells (>95%), as determined by expression 
of sIg and  B220.  Each of the  mouse IgG subclasses, IgG1,  IgG2a,  and  IgG2b 
(Fig.  1 a) and each of the rat IgG subclasses, IgG1,  IgG2a, and IgG2b (Fig.  1 b) 
bind to mouse B cell blasts in similar amounts. 
To  determine  whether  one  or  more  Fc  receptors  was  responsible  for  the 
binding of rat and  mouse IgG subclasses to B cells, a  series of inhibition  assays 
were performed.  The  assays are based on the  inhibition  of a  standard  labeled 
IgG  by  known  quantities  of purified  representatives  of the  IgG  subclasses. 
Histograms  demonstrating  the  inhibition  of  biotin-conjugated  mouse  IgG2a 
(LPC-1, UPC-10) and IgG2b (MPC-11, 29-13), as well as rat IgG2b (EA4.1), are 
shown in Fig. 2, a-c, respectively. Fc-mediated binding of mouse IgG2a (LPC-1, 
U PC- 10) is inhibited by both aggregated IgG2a (LPC- 1, U PC- 10) and aggregated 
IgG2b (MOPC-195,  MPC-11) (Fig.  2a, Table  I).  Similarly,  the  binding  of the 
IgG2b (MPC-11, 29-13) standard  is inhibited by immunoglobulins of the IgG2a 
(LPC-1) and  IgG2b  (MOPC-195,  MPC-11)  subclasses (Fig.  2  b,  Table  I).  The 
binding of IgG1  (HDP-1) to the  Fc receptor is inhibited  by IgG1,  IgG2a,  and 
IgG2b (data not shown).  Thus,  we conclude that  the IgG1,  IgG2a, and  IgG2b 
all  bind  to  the  same  Fc  receptor.  Further,  the  concentration  of competing 
antibody that provides maximal inhibition of the IgG 1, IgG2a, or IgG2b standard 
proteins is the same in all cases (~750 #g/mi of LPC-1, MPC-11, MOPC-21, or 
MOPC-195).  Fig.  2c illustrates  that  rat  IgG2b (EA4.1,  148d4-1) is specifically 
inhibited  by mouse  IgGl  (MOPC-21),  IgG2a  (LPC-1),  and  IgG2b  (MPC-11). 
The rat IgG2b appears to bind the mouse B cell IgG1/IgG2a/IgG2b Fc receptor, 
because it is inhibited  by each of these subclasses. Table ! summarizes the data 
from  several  inhibition  experiments.  The  results  show that  representatives  of 
IgG1, IgG2a, and IgG2b subclasses can each inhibit Fc binding of IgG1, IgG2a, 
or IgG2b. These data support the existence of one Fc receptor that binds each 
of the three IgG subclasses, IgG1,  IgG2a, and IgG2b.  Elsewhere, we will show 
evidence for a  second  Fc receptor on  B  cells that  binds  mouse IgG3  and  the 
related rat  IgG2c. z Our findings on the B cell  Fc receptor stand in contrast to 
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FIGURE  1.  Binding of mouse and rat lgG subclasses to mouse B cell blasts. BALB/c cell blasts 
were  exposed  to  (A)  normal  mouse  serum  (NMS) or  ~300  ug/ml  of either  purified  mouse 
IgGl,  IgG2a, or IgG2b, and (B) normal rat serum (NRS) or ~300  ug]ml of either purified  rat 
lgG1,  lgG2a,  or  IgG2b.  Binding  was  assessed  by  indirect  immunofluorescence  and  flow 
microfluorometry. 
the Fc-binding activities expressed by mouse macrophages, where one Fc receptor 
appears  to  bind  the  IgG1  and  IgG2b  subclasses  and  another  receptor  binds 
IgG2a (2, 6-8,  38, 40, 41, 47). 
Polymorphism  in the B Cell Fc Receptor.  An examination of rat IgG Fc binding 
to the B lymphocytes of various mouse strains indicates that most strains exhibit 
relatively high levels of rat IgG binding. The strain survey was initially performed 
using rat IgG2b proteins (EA4.1,  148d4-1) and, subsequently, strains were tested 
for IgG1  and IgG2a binding.  Lymphocytes from A/J, AL/N, and NZB/J strains 
expressed significantly lower levels of rat IgG binding (3.5-7-fold). Fig. 3 a shows 
a comparison of the Fc binding exhibited by the B cell blasts of BALB/c mice, a 
high Fc-binding strain,  to the B cell blasts of A/J mice.  It should also be noted 
that  the  difference  in  binding  of  rat  IgG  occurred  in  unstimulated  splenic 
lymphocytes as well as in B cell blasts (Fig.  3 b). The strain survey of rat IgG Fc 
binding  is summarized  in  Table  II.  Mouse  IgG1,  IgG2a,  and  IgG2b subclasses 
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FIGURE 2.  Specificity  of B cell Fc receptors.  BALB/c B cell blasts were exposed to F1TC- 
labeled (Fl) immunoglobulins (-50 #g/ml) and -750 #g/ml of unlabeled,  aggregated  immu- 
noglobulins as inhibitors:  (A) FITC-mouse IgG2a (LPC-1)  binding inhibited by aggregated 
mouse IgG2a  and lgG2b proteins,  (B)  FITC-mouse lgG2b (MPC-I 1) binding inhibited by 
aggregated  mouse  lgG2a  and  lgG2b  proteins,  and (C)  FITC-rat lgG2b (EA4.1) binding 
inhibited by aggregated mouse lgG1, IgG2a, and IgG2b subclasses. 
strains,  as  illustrated  in  Fig.  4.  Further,  B  cell  blasts  of the  BALB/c  and  A/J 
mouse  strains  exhibit  equivalent  binding  of a  monoclonal  antibody  (2.4G2) 
specific for the IgG1/IgG2b  Fc receptor previously described by Unkeless et al. 
(25). Therefore, we conclude that the variation in binding of rat IgG subclasses 
is the result of a difference in specificity rather than a difference in the number 
of Fc receptors on mouse B lymphocytes. 
An examination  of the strain survey  indicates a possible correlation between 
low  Fc binding and  Igh  haplotype.  All conventional  strains of the Igh-C e,  Igh- 
C",  and  Igh-C °  haplotypes  are  low  binders  of rat  IgG.  These  haplotypes  are 
similar:  the NZB/J strain matches the A/J Igh-C haplotype in the Igh-3 (IgG2b), 
Igh-1 (IgG2a), and Igh-2 (IgA) loci, and the AL/N strain matches A/J at the Igh- 
4  (IgG1), Igh-5 (IgD),  and Igh-6 (IgM)  loci  (64).  The  allotype-congenic  strains 
C.AL9  and C.AL20  express  the IgCH ° haplotype of AL/N  mice but carry the 
prealbumin and Lm-1 alleles of the BALB/c strain, which expresses high rat IgG 
binding (51). B cells of the C.AL9 and C.AL20 mice bind high levels of rat IgG 
in contrast to AL/N mice, thereby suggesting that the FcR locus might be in the 
neighborhood of the prealbumin locus. 
Although  suggestive,  the  strain  survey  does  not  prove  linkage  to lgh.  We 
therefore undertook an examination of backcross mice in order to further clarify 288  POLYMORPHISM  OF  THE  FcT  RECEPTOR 
TABLE  I 
Spec~city of Binding to Fc Receptors on BALB/c B Cells* 
FACS chan-  Percent 
Stain  Inhibitor  nel shift*  inhibition  ~ 
FITC-Mouse IgG1  No inhibitor  30  0 
Mouse IgG2a  3  79 
IgG2b  5  69 
IgG1  9  50 
FITC-Mouse IgG2a  No inhibitor  47  0 
Mouse IgG2a  7  71 
IgG2b  9  63 
IgG1  12  55 
FITC-Mouse IgG2b  No inhibitor  59  0 
Mouse IgG2a  6  79 
IgG2b  6  79 
IgG 1  16  54 
FITC-Rat IgG2b  No inhibitor  67  0 
Mouse lgG1  16  58 
IgG2a  8  76 
IgG2b  6  81 
* See Fig. 2. 
* FACS channel shifts represent the difference in  relative fluorescence 
intensity between  control  and  experimental  groups on  a  logarithmic 
scale (60 channels represent 10-fold). 
Percent inhibition is determined by the formula: log  -t  [(channel shift 
with no inhibitor) -  (channel shift with inhibitor)/(channel shift with no 
inhibitor)] x  10. The percent inhibition represents the mean of two or 
more experimental determinations. 
this relationship.  Backcross [(C57BL/6J x  A/J)Fl x  A/J] mice were analyzed for 
Igh haplotype as well as for Fc binding  of rat  immunoglobulins.  Igh haplotype 
was determined by typing of IgM and IgD allotypes with allotype-specific mono- 
clonal antibodies (58, 60). The Fc-binding characteristics of heterozygotes were 
similar  to  those of homozygous high  binders and  were clearly  distinguishable 
from  low  Fc-binding  mice.  The  results  of the  backcross  analysis  (Table  III) 
indicate that  there is loose, but significant,  linkage of the Fc receptor polymor- 
phism to the heavy chain locus. The recombination frequency is ~32% with a P 
value <0.005.  We find no evidence for linkage to the H-2 locus as shown by H- 
2 congenics (Table II) or by analysis of backcross mice (Table III); [:n addition, 
no linkage was found to the x chromosome.  As a further control we examined 
Igh linkage  to H-2: no linkage  was found.  The  backcross experiments  provide 
additional  evidence for a  linkage  of the  Fc receptor polymorphism  to the Igh 
locus. 
To further define the genetic linkage of the Fc receptor polymorphism to the 
Igh locus,  we undertook  an  examination  of Igh recombinant  mouse lines (51). 
Several mice of each line were tested individually for Fc binding of rat  IgG2b 
and for Igh-6 (IgM) and Igh-5 (IgD) allotypes (58, 60). These results are shown 
in  Table  IV.  The Igh recombinant  strain  analysis is  consistent  with  moderate 03 
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FIOURE 3.  Comparison of rat IgG binding by B cells from A/J and BALB/c  mice. (A) A/J 
and BALB/c B cell blasts were exposed to normal rat serum (NRS) or -300 #g/ml of purified 
rat IgG1, lgG2a, and IgG2b, and (B) A/J and BALB/c spleen cells were exposed to -300 ug/ 
ml of rat IgG2b. Binding was assessed by indirect immunofluorescence and flow microfluoro- 
metry. 
linkage  of the  FcR  polymorphism  to  the  Igh locus  on  chromosome  12.  This 
analysis indicates a  higher  degree  of linkage  with the Pre-I  and Lm-1 loci that 
map 10 and  15 map units telomeric to Igh-C, and places the FcR locus ~20 map 
units distal  to Lm-l, at the end of chromosome  12 near the Ly-7  locus (51).  A 
genetic  map of chromosome  12  showing  the  apparent  location  of the  gene(s) 
responsible for the Fc receptor polymorphism is shown in Fig. 5. 
Discussion 
There  has been  relatively  little work reported on the IgG subclass specificity 
of  mouse  B  lymphocyte  Fc  receptors.  Lane  et  al.  (20)  showed  that  a  non- 
immunoglobulin-producing  B  lymphocyte  cell  line  expressed  an  Fc  receptor 
activity  specific  for the  IgG1/IgG2a/IgG2b  subclasses  (20).  In  this  report,  we 
extend these results to normal B  lymphocytes that express a single  Fc receptor 
which  binds  the  IgG1,  IgG2a,  and  IgG2b  subclasses.  In  results  reported  else- 
where, 2 we show that there  is an additional  Fc  receptor  specific  for IgG3.  We 
also find that rat IgG1, IgG2a, and IgG2b bind to the same receptor that binds 
mouse  IgG1,  IgG2a,  and  IgG2b.  We  conclude  that  the  B  cell  IgG1/IgG2a/ 
IgG2h  receptor  is  probably  distinct  from  macrophage  Fc  receptors,  because 
mouse macrophages  apparently  possess one  receptor  for IgG1/IgG2b  and an- 290  POLYMORPHISM  OF  THE  Fc~, RECEPTOR 
TABLE  II 
Strain Survey of Fc Receptor Phenotype 
Strain  Igh-C allotype  Fc binding  of rat lgG 







b  High 
DBA/2J 
DBA/212Ha 
c  High 
AKR/J  d  High 
CE/J  f  High 
P/J  h  High 
CBA/J 
PL/J 





e  Low 
NZB/J  n  Low 
AL/N  o  Low 
C.AL-9  o  High 
C.AL-20  o  High 
other for IgG2a. In addition, clear biochemical differences occur between the 
IgG  Fc  receptors  of B  cell  and  macrophage  cell  lineages  in  mice  as  well  as 
humans, although the nature of these differences remains undetermined (20, 
24, 26, 65). 
The other interesting observation made in this report is that a polymorphism 
occurs in the mouse B lymphocyte IgG Fc receptor. A strain survey shows that 
A/J, AL/N, and NZB/J mice bound low levels of rat IgG compared with other 
strains. Backcross analysis and examination of Igh recombinant strains indicate 
that the Fc receptor polymorphism maps telomeric to the lgh region at or near 
the end of chromosome 12. 
Biochemical studies are currently under way to determine whether the poly- 
morphism arises from a  difference in primary structure or from differences in 
posttranslational modification. Recently (66),  a polymorphism in an IgE-binding 
factor was described which is apparently the result of differences in oligosaccha- 
ride processing. The B cell Fc receptor polymorphism is expressed as a difference 
in the specificity of the receptor for its ligand. This polymorphism may therefore BAUM,  McKEARN,  RIBLET,  AND  DAVIE  291 
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FTCURE 4.  Comparison of mouse lgG binding by B cell blasts from A/J and BALB/c mice. 
B cell blasts were exposed to normal mouse serum (NMS) or ~300 #g/ml of purified mouse 
IgGl,  lgG2a,  and  IgG2b.  Binding was  assessed  by  indirect immunofluorescence and  flow 
microfluorometry. 
TABLe:  III 
Segregation Analysis of FcR, Igh-C, and I-A in Backcross Mice 
Fc binding 
High  Low 
Probability 
of linkage 
Comparison of inheritance of FcR and IgM allotype b 
lgM allotype b  +(b/e)  26*  11  P <  0.005 
-(e/e)  14  27 
Comparison of inheritance of FcR and I-A  b 
1-A  b  Probability 
of linkage 
Fc binding  High  12  11  P =  0.5 
Low  9  15 
Comparison of inheritance of I-A  b and IgM allotype b 
I-A  b  Probability 
of linkage  + 
IgM allotype b  +(b/e)  12  11  0.25 <  P <  0.5 
-(e/e)  8  16 
(C57BL/6 X A/J)FI ×  A/J mice were tested for immunoglobulin allotype using monoclonal anti- 
Igh-6  a'b'c'a'chd (58),  for  FcR  phenotype  using rat  lgG2b  (EA4.1),  and  for  I-A  expression  using 
monoclonal anti-I-A  b (59). 
* Number of individual backcross mice. 
shed some light on the nature of the IgG Fc receptor's binding site and those 
factors  that  affect  the  receptor's  specificity.  A  polymorphism  in  the  human 
monocyte IgG  Fc receptor has recently been described (67,  68),  although no 
chromosomal assignment has yet been made. Furthermore, the linkage of the 
murine monocyte/macrophage IgG Fc receptor is unknown. Since the B cell and 
macrophage IgG Fc receptors differ from one another biochemically and in their 
specificity (26, 65, and this report), it would be interesting to compare the linkage 292  POLYMORPHISM  OF  THE  Fc3,  RECEPTOR 
TABLE  IV 
B Cell Fc Receptor Typing of Igh Recombinant Strains 
lgh-V  lgh-C  Tind  Tsu  Tpre  Pre-1  Lm-1  B  cell FcR 
BALB/C  a  a  a  a  a  a  a  +  (High) 
A/He  e  e  e  e  e  0  b  -  (Low) 
Strain 
AXC-I*  a  X  e  e  e  e  0 
-2  a  X  e  e  e  e  0 
-3  a  X  e  e  e  e  0  X  + 
-4  a  X  e  e  e  e  0 
-5  a  X  e  e  e  e  0  b  - 
-6  a  X  e  e  e  e  0  b  - 
-7  e  X  a  a  a  a  a  a  + 
-8  e  X  a  a  a  a  X  0  b  - 
-9  e  X  a  a  a  a  a  a  + 
-10  e  X  a  a  a  a  X  0  b  - 
-11  e  X  a  X  e  e  e  0  X  a  X  - 
-12  e  X  a  X  e  e  e  0  b  - 
CXAXCB-I*  e  e  e  e  e  X  a  a  + 
-2  a  a  a  a  a  X  0  X  a  + 
-3  e  e  X  a  a  a  a  a  + 
-4  e  e  X  a  a  a  a  a  + 
-5  e  e  X  a  a  a  a  a  + 
-6  e  a  X  e  e  e  0  b  X  + 
-7  a  a  a  a  X  e  0  b  X  + 
*  AXC  strains are  recombinant  between  Igh-V  and Igh-C (49-51). 
* CXAXCB  strains are  recombinant  between  Igh-C and Pre-1 (51). 
the  parental  strains. 
BALB/c,  A/He,  and  C.B-17  are 
Ceniromere  hyt 
Lyb-7 
Ly - Iro 
FIGURE  5, 
FcR 
Igh  Tsu  Pre-I  Lm-I  Polym~phism 
1.---4~F,,.---6  ~I=  5--"t"  20  • 
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Genetic  map  of chromosome  12.  Modified  from  reference  5 I. 
of the B cell and macrophage Fc receptor loci to determine if they map to the 
same location and form a cluster of related genes. 
Fc  receptors  may  play  a  critical  physiologic  role  in  B  cell  development, 
differentiation, or function. We are currently attempting to exploit the B cell Fc 
receptor polymorphism to further elucidate the functional role of Fc receptors 
in B lymphocyte biology. 
Summary 
Analysis of mouse IgG binding to Fc receptors on mouse B cells indicates that 
the IgG1, IgG2a, and IgGb subclasses bind to the same receptor. No differences 
in affinity were detected among subclass or between mouse strains.  This same BAUM, McKEARN, RIBLET, AND DAVIE  293 
receptor bound rat  IgG with  an  affinity  that  differed  between  mouse  strains. 
This polymorphism in affinity for rat IgG maps to chromosome 12 distal to the 
Igh locus. 
Received for publication 21 February 1985. 
Note added in proof." Since submission of this manuscript, Teillaud et al. (]. Immunol. 134:1774) 
have reported  that a single receptor activity accounts for the binding of IgG1, IgG2a, and IgG2b 
antibodies to murine myeloma and hybridoma cell lines, consistent with our findings. 
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